<DOC>
	<DOCNO>NCT00339833</DOCNO>
	<brief_summary>This study , conduct Phoenix Indian Medical Center , Phoenix , Arizona , determine whether reduce subclinical inflammation lessen insulin resistance healthy , obese volunteer . The study finding may lead new strategy prevent type 2 diabetes . In diabetes , blood sugar high normal result serious medical problem , blindness kidney failure . People subclinical inflammation-inflammation produce symptom , fever , pain , skin redness-are increase risk diabetes . Although reason completely understood , known subclinical inflammation exacerbate insulin resistance , cause diabetes . Insulin hormone help control blood sugar , work properly , condition know insulin resistance . Normal , healthy volunteer 18 45 year old body mass index least 30 kg/m2 subclinical inflammation ( determined blood test ) may eligible study . Candidates must non-smokers must alcohol drug problem . Candidates screen medical history physical examination , electrocardiogram , blood urine test . Participants maintain standard diet undergo test procedures 14-day inpatient stay Phoenix Indian Medical Center .</brief_summary>
	<brief_title>The Effects Anti-Inflammatory Treatment Insulin Resistance Healthy Volunteers</brief_title>
	<detailed_description>In healthy subject , low-grade inflammation , measure serum level cytokine acute phase protein , positively associate adiposity . Recent study indicate chronic low-grade inflammation non-diabetic individual may cause decline insulin sensitivity increase risk develop type 2 diabetes . It propose reduction low-grade inflammation may reduce risk development type 2 diabetes . In agreement hypothesis , class anti-inflammatory drug call salicylate ( aspirin ) influence specific anti-inflammatory pathway find decrease plasma glucose level increase insulin sensitivity rodent well people type 2 diabetes . In present study , propose test whether administration anti-inflammatory drug Salsalate improve insulin sensitivity obese non-diabetic individual whether improvement relate decrease serum marker inflammation . Subjects randomly assign two treatment group : placebo Salsalate ( 3g/d ) . An oral glucose tolerance test combine euglycemic/hyperglycemic clamp ass insulin sensitivity insulin secretion perform seven day treatment . Results study may help identify novel strategy prevent type 2 diabetes high-risk group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>INCLUSION CRITERIA : Age : Greater 18 less 45 year . Number : 44 complete study ( 22 placebo , 22 Salsalate ) . Sex : 22 Males 22 Females . BMI : Greater equal 30 kg.m ( 2 ) EXCLUSION CRITERIA : Age 18 45 year minimize risk glucose clamp . Diabetes mellitus ( per 75 g OGTT , WHO 1999 criterion ) Cardiovascular disease include : abnormal EKG , personal history coronary heart disease ; symptomatic angina pectoris cardiac insufficiency define NYHA ; classification functional class III IV . Systolic blood pressure great 160mmHG and/or diastolic blood pressure great 100 mmHg and/or antihypertensive therapy rest heart rate great 90 bpm . Hematological disorder , include prolonged prothrombin time ( normal range 10.912.9 sec ) partial thromboplastin time ( 2436 sec ) thrombocytopenia ( le 150,000 mm ( 3 ) ) . Respiratory disease ( include influenza , asthma ) Allergies ( include hay fever ) Gastrointestinal ( include peptic ulcer ) , hepatic renal disease ( ALT AST great 3fold upper limit normal range , creatinine great 1.3 mg/dl ) . Alcoholism , alcoholinduced autonomic neuropathy . Any endocrinological disorder , include hypopituitarism/pituitary dysfunction lesion , hypo/hyperthyroidism , insulinoma . CNS disease Psychosis personal history psychiatric disorder . Taking medication within one month prior begin study , include medication know pharmacological interaction salicylate may affect insulin sensitivity secretion ( include salicylate , COX 1 COX 2 inhibitor , warfarin , BetaBlockers , phenothiazine , antidepressant , antiarrhythmic drug , antimuscarinic drug ) . Acute inflammation assess history , physical laboratory examination ( subject Creactive protein 2 standard deviation population mean admit ) . The population mean calculate subject admit research unit . Pregnant lactating female females hormonal contraceptive . History metabolic acidosis . Allergy aspirin , salicylate , bleed diathesis currently oral anticoagulant . Any current viral illness . Active cancer within 5 year prior screen study . Positive urine drug screen test . Inability provide inform consent . Smokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Salsalate</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Diabetes</keyword>
	<keyword>HCV</keyword>
</DOC>